Pre-treatment [ 18 F]FDG PET/CT for Assessing Bone Marrow Involvement and Prognosis in Patients with Newly Diagnosed Peripheral T-cell Lymphoma

Purpose To explore the value of [18F]fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in assessing bone marrow involvement (BMI) and prognosis in newly diagnosed peripheral T-cell lymphomas (PTCLs) before treatment.